An engineered vascular endothelial growth factor-activating transcription factor induces therapeutic angiogenesis in ApoE knockout mice with hindlimb ischemia
- 31 July 2006
- journal article
- Published by Elsevier in Journal of Vascular Surgery
- Vol. 44 (1) , 166-175
- https://doi.org/10.1016/j.jvs.2006.03.024
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Delayed Arteriogenesis in Hypercholesterolemic MiceCirculation, 2005
- Engineered Zinc Finger–Activating Vascular Endothelial Growth Factor Transcription Factor Plasmid DNA Induces Therapeutic Angiogenesis in Rabbits With Hindlimb IschemiaCirculation, 2004
- Gene delivery approaches to heart failure treatmentExpert Opinion on Biological Therapy, 2004
- Preclinical models of human peripheral arterial occlusive disease: implications for investigation of therapeutic agentsJournal of Applied Physiology, 2004
- Vascular Endothelial Growth Factor Modulates Skeletal Myoblast FunctionThe American Journal of Pathology, 2003
- Gene Therapy for Atherosclerotic Cardiovascular Disease: A Time for Optimism and CautionMayo Clinic Proceedings, 2000
- Modulation of Tissue Factor Protein Expression in Experimental Venous Bypass GraftsArteriosclerosis, Thrombosis, and Vascular Biology, 1997
- The Biology of Vascular Endothelial Growth FactorEndocrine Reviews, 1997
- Epidemiology of Peripheral Arterial DiseaseJournal of Cardiovascular Pharmacology, 1994
- The prevalence of peripheral arterial disease in a defined population.Circulation, 1985